Physician profile
Steven C Schmidt
NPI 1831116797
$1,830.69
in general payments reported to CMS, 2019-2025
12 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $310 · 2021: $157 · 2022: $231 · 2023: $436 · 2024: $168 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $541.84 | 2019-2025 | |
| Mentor Worldwide LLC | $358.89 | 2019-2023 | Artoura Breast Tissue Expander |
| Abbvie INC. | $312.89 | 2020-2023 | Botox, Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $200.83 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $113.66 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $85.47 | 2023-2024 | |
| Integra Lifesciences Corporation | $79.55 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Janssen Biotech, INC. | $64.63 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $28.36 | 2019-2022 | |
| Astellas Pharma US INC | $17.59 | 2022 | |
| Lilly USA, LLC | $15.24 | 2019 | |
| Sun Pharmaceutical Industries INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.